Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, February 28, 2022
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
Yigal Nochomovitz Maintained (ZYME) at Strong Buy with Decreased Target to $30 on, Feb 28th, 2022
Yigal Nochomovitz of Citigroup, Maintained "Zymeworks Inc." (ZYME) at Strong Buy with Decreased Target from $53 to $30 on, Feb 28th, 2022.
Yigal has made no other calls on ZYME in the last 4 months.
There are 3 other peers that have a rating on ZYME. Out of the 3 peers that are also analyzing ZYME, 0 agree with Yigal's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Yigal
- Jim Birchenough of "Wells Fargo" Maintained at Buy with Decreased Target to $48 on, Wednesday, February 9th, 2022
- Andrew Berens of "SVB Leerink" Upgraded from Hold to Buy on, Friday, December 10th, 2021
- David Novak of "Raymond James" Downgraded from Strong Buy to Buy and Held Target at $74 on, Friday, December 10th, 2021
